MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways

作者：Hoshi Hirotaka; Sawada Tetsuji^*; Uchida Motoyuki; Iijima Hiroko; Kimura Kenjiro; Hirakawa Kosei; Wanibuchi Hideki

来源：International Journal of Oncology, 2013, 42(3): 887-893.

DOI：10.3892/ijo.2013.1760

• MUC5AC
• mucin
• pancreatic cancer
• short interfering RNA
• TNF-related apoptosis-inducing ligand
• apoptosis

We have previously reported that a specific siRNA transfected MUC5AC could knockdown MUC5AC expression and suppress in vivo tumor growth and metastasis, although it had no effects on in vitro cell growth, cell survival, proliferation and morphology. In the present study, we investigated which host immune cells induced these effects and how the effects were induced using immunocyte-depleted animal models. The tumor growth of SW1990/si-MUC5AC cells, which show no tumor growth when implanted subcutaneously into a nude mouse, was recovered when neutrophils were removed by anti-Gr-1 mAb administration. This result suggests that MUC5AC may suppress the antitumor effects of neutrophils by allowing tumor cells to escape the host immune system. Subsequently, we investigated the effects of MUC5AC on apoptosis induction mediated by TNF-related apoptosis-inducing ligand (TRAIL), one of the antitumor mechanisms of neutrophils. SW1990/si-MUC5AC cells showed significantly increased active caspase 3 expression after the addition of TRAIL. On the other hand, SW1990/si-mock cells showed no such changes. Our results indicate that MUC5AC inhibits TRAIL-induced apoptosis in human pancreatic cancer and may serve as an important indicator in diagnosis and prognosis.

• 出版日期2013-3